ICL670F2202: A randomized, open-label, multicenter, two arm, phase II study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload

Project: Research project

Project Details

StatusFinished
Effective start/end date7/1/163/31/20

Funding

  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals Corporation